NESRI Media Center

Congress deregulates drug and medical device approval, Tom Price tapped to head HHS

Printer-friendly version
Publication Date: 
December 23, 2016

Under enormous lobbying, Congress passes 21st Century Cures Act to deregulate drug and device approval

In its final days in session, Congress passed a major healthcare bill that will reshape federal regulations of drugs and medical devices for years to come. The bill, the 21st Century Cures Act, was the culmination of two decades of work by drug companies and conservative think tanks and one of the most-lobbied for pieces of legislation in years: at least 1,455 lobbyists from companies, universities and other organizations lobbied Congress on the bill, spending some $200 million to get it passed.

Though the bill’s backers are touting it’s passage with a large bipartisan majority, the bill will allow drug corporations to make enormous profits by rushing medicines and medical devices to the market before they are adequately tested for safety, putting people’s lives at risk in order to open up enormous profit opportunities for corporations. Read the full story in a fantastic article by Trudy Lieberman at Health News Review.

Tom Price tapped to head HHS

President-Elect Donald Trump has chosen Georgia Congressman Tom Price as his nominee for the Secretary of Health and Human Services. Price is known as a fierce opponent of the Affordable Care Act (ACA). He introduced H.R. 2300 to dismantle the ACA last year. Though it was vetoed by President Obama, under President Trump the bill will serve as a blueprint for the coming repeal. Price is a proponent of slashing funding for Medicare, Medicaid, and other social protection programs by granting tax cuts to the wealthy. For more on what to expect, see our analysis of the coming attacks on health care.

Latest Photos

Latest Video

Latest Podcast